1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am...

15
1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384

description

3 CRC Screening FOBT has the most RCT evidence to support a reduction in CRC mortality FOBT is also less expensive than the other alternatives and is the only strategy that many health-care systems can afford. Is the endpoint of CRC death an ideal endpoint? Maybe “all cause” mortality should be the most appropriate outcome to evaluate. FOBT has the most RCT evidence to support a reduction in CRC mortality FOBT is also less expensive than the other alternatives and is the only strategy that many health-care systems can afford. Is the endpoint of CRC death an ideal endpoint? Maybe “all cause” mortality should be the most appropriate outcome to evaluate.

Transcript of 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am...

Page 1: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

1

Does Fecal Occult Blood Testing Really Reduce Mortality? A

Reanalysis of Systematic Review Data

Am J Gastroenterol 2006;101:380–384

Page 2: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

2

CRC Screening

• The choices available for CRC screening are: FOBT flexible sigmoidoscopy every 5 yr colonoscopy every 10 yr CT colography

Page 3: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

3

CRC Screening

• FOBT has the most RCT evidence to support a reduction in CRC mortality

• FOBT is also less expensive than the other alternatives and is the only strategy that many health-care systems can afford.

• Is the endpoint of CRC death an ideal endpoint? Maybe “all cause” mortality should be the most appropriate outcome to evaluate.

Page 4: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

4

CRC Screening

• The value of FOBT in preventing CRC mortality is accepted.

• This study evaluates whether FOBT reduces all cause mortality as an outcome.

Page 5: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

5

CRC Screening

מביא screening ל-FOBTשימוש ב-•.CRC בתמותה מ-16%ירידה של

Page 6: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

6

במטה-אנליזה נכללו שלושה מחקרים•

רקע

Mandel et al. N Engl J Med 1993;328;1365–71.Scholefield et al. Gut 2002;50:840–4.Jorgensen et al. Gut 2002;50:29–32.

Page 7: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

7

CRC mortality in FOBT arm compared with no screening arm

תוצאות

מביא screening ל-FOBTשימוש ב-•.CRC בתמותה מ-13%ירידה של

Page 8: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

8

mortality not due to colorectal cancer in FOBT arm compared with no screening arm.

תוצאות

screening ל-FOBTשימוש ב- את שיעור התמותה מעלה

!!מסיבות שאינן קשורות ל- CRC

Page 9: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

9

all cause mortality in FOBT arm compared with no screening arm.

תוצאות

לא screening ל-FOBTשימוש ב-• על שיעור התמותה מסיבה משפיעכלשהי.

Page 10: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

10

דיון• Concern with using all cause mortality as an

outcome is that the power to detect clinically meaningful differences is diminished.

• The analysis of the data suggests that FOBT has no impact in overall mortality as there is an excess of deaths from non-CRC causes.

• This seems counterintuitive as FOBT is an innocuous test and it is hard to conceive that this would result in death.

• Assuming that this is not a chance finding, there are three explanations for this unexpected result.

Page 11: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

11

Iהסבר • If a screening program reduces CRC deaths

and subjects are followed up for long enough they will die from something else and there will be an apparent excess mortality from other causes.

• The problem with this explanation is that the follow-up in these trials has been for less than 13 yr in most cases with only 26% of subjects dying so far.

Page 12: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

12

IIהסבר • These trials were all open label. The behavior

of both the subjects and the clinicians looking after them may be affected by the knowledge that FOBT has taken place.

• This bias would be particularly important when assessing the cause of death.

Page 13: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

13

IIIהסבר • FOBT screening results in a real increase in

deaths from other causes. It is not conceivable that this is due to the test directly but there are biologically plausible reasons why the psychological effects of screening may increase mortality.

• Subjects taking part in screening may feel that this protects them from harm and conduct a lifestyle that increases their risk of mortality.

Page 14: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

14

קיים הסבר נוסף מופיע שאינו

במאמר

Page 15: 1 Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data Am J Gastroenterol 2006;101:380–384.

15

ההסבר IVהסבר יש טעות בחישובים של המאמר. אין הבדל •האולטימטיבי

בשיעור התמותה מסיבה שלא קשורה ל- CRC.

בעבודה של RRלפי המאמר ה- •Schoiefield אך בפועל ה- 1.03 הוא ,RR

!!1.007הוא לתמותה שלא Pooled RRלפי המאמר ה- •

, אך בחישוב 1.02 הוא CRCקשורה ל- עם RR=1.007שעשינו קבלנו

CI=(0.993,1.021)!

אין תקפות למאמר !!!!